{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:04:04Z","timestamp":1790726644832,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018707","name":"European Commission Reforming and enhancing the European Research and Innovation system","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rpth.2026.103427","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:09:50Z","timestamp":1774465790000},"page":"103427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7571-4820","authenticated-orcid":false,"given":"Elin","family":"Baddeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sivell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"Lifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Mailen","family":"Arfuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Coma-Auli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"S\u00f8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Enggaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Helfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassima Si","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Mooijaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Szmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette Arbjerg","family":"H\u00f8jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103427_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bmj.329.7471.909","article-title":"Managing comorbidities in patients at the end of life","volume":"329","author":"Stevenson","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.103427_bib2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/pds.5223","article-title":"Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases","volume":"30","author":"Bosetti","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rpth.2026.103427_bib3","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1111\/bcp.13735","article-title":"Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life\u2014an international cohort study","volume":"84","author":"Todd","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2026.103427_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12904-021-00786-3","article-title":"Use of antithrombotics at the end of life: an in-depth chart review study","volume":"20","author":"Huisman","year":"2021","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.rpth.2026.103427_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jtha.2024.09.023","article-title":"Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study","volume":"23","author":"S\u00f8gaard","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103427_bib6","article-title":"Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer","volume":"245","author":"Martens","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103427_bib7","first-page":"401","article-title":"Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease","volume":"125","author":"Kempers","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103427_bib8","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bjh.70032","article-title":"Anti-thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: a cohort study using population-linked routinely collected data","volume":"207","author":"Aldridge","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.103427_bib9","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/j.1538-7836.2006.02082.x","article-title":"Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: Findings from the RIETE registry","volume":"4","author":"Monreal","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103427_bib10","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1136\/bmjspcare-2019-001804","article-title":"Management of venous thromboembolism in far-advanced cancer: current practice","volume":"12","author":"Noble","year":"2022","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.rpth.2026.103427_bib11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1089\/jpm.2024.0108","article-title":"Treatment with antithrombotics in the last year of life\u2014incidence of bleeding and side effects after deprescribing","volume":"27","author":"Frisk","year":"2024","journal-title":"J Palliat Med"},{"key":"10.1016\/j.rpth.2026.103427_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.12968\/ijpn.2011.17.1.7","article-title":"Coping and supportive mechanisms for managing challenging situations in palliative care: a qualitative account of nurses experiences of managing terminal haemorrhage","volume":"17","author":"Harris","year":"2011","journal-title":"Int J Palliat Nurs"},{"key":"10.1016\/j.rpth.2026.103427_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jpainsymman.2009.04.027","article-title":"Management of terminal hemorrhage in patients with advanced cancer: a systemic literature review","volume":"38","author":"Harris","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.rpth.2026.103427_bib14","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.103427_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rpth.2026.103427_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.103427_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0041-1726298","article-title":"Single, dual, and triple antithrombotic therapy in cancer patients with coronary artery disease: searching for evidence and personalized approaches","volume":"47","author":"Santoro","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.103427_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/mja2.51686","article-title":"Establishing the worth of deprescribing inappropriate medications: are we there yet?","volume":"217","author":"Scott","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.rpth.2026.103427_bib19","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1177\/1049732316687732","article-title":"Negotiating \u201cunmeasurable harm and benefit\u201d: perspectives of general practitioners and consultant pharmacists on deprescribing in the primary care setting","volume":"27","author":"Anderson","year":"2017","journal-title":"Qual Health Res"},{"key":"10.1016\/j.rpth.2026.103427_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12904-024-01523-2","article-title":"\u201cStarting to think that way from the start\u201d: approaching deprescribing decision-making for people accessing palliative care\u2014a qualitative exploration of healthcare professionals views","volume":"23","author":"Robinson-Barella","year":"2024","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.rpth.2026.103427_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2023.05.008","article-title":"Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool","volume":"228","author":"Goedegebuur","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103427_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004663","article-title":"Shared decision-making and deprescribing to support anti-thrombotic therapy (dis) continuance for persons living with cancer in their last phase of life: a realist synthesis","volume":"22","author":"Jagosh","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.rpth.2026.103427_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109399","article-title":"\u201cWho am I to say that I'm not going to take it\u201d: patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer","volume":"253","author":"Baddeley","year":"2025","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103427_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109573","article-title":"Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: results of a European Delphi study","volume":"258","author":"Mah\u00e9","year":"2026","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103427_bib25","series-title":"Guidelines for reporting health research: a user\u2019s manual","first-page":"214","article-title":"COREQ (consolidated criteria for reporting qualitative studies)","author":"Booth","year":"2014"},{"key":"10.1016\/j.rpth.2026.103427_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19830","article-title":"A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)","volume":"19","author":"Noble","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.rpth.2026.103427_bib27","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1353\/hcr.2005.0096","article-title":"Living long in fragile health: the new demographics shape end of life care","author":"Lynn","year":"2005","journal-title":"Hastings Cent Rep"},{"key":"10.1016\/j.rpth.2026.103427_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.rpth.2026.103427_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2024.100196","article-title":"Involving patients and the public in cancer associated thrombosis research: a strategy for success","volume":"18","author":"Edwards","year":"2025","journal-title":"Thromb Update"},{"key":"10.1016\/j.rpth.2026.103427_bib30","series-title":"Public Involvement in Research Impact Toolkit (PIRIT)","year":"2023"},{"key":"10.1016\/j.rpth.2026.103427_bib31","article-title":"Are we comfortable managing oral anticoagulation at the end of life? A national survey of secondary care clinicians in the UK","volume":"25","author":"Shevlin","year":"2025","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.rpth.2026.103427_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-med-070822-101947","article-title":"Polypharmacy and deprescribing in older adults","volume":"75","author":"Thompson","year":"2024","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.rpth.2026.103427_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0269216318801124","article-title":"Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review","volume":"33","author":"Paque","year":"2019","journal-title":"Palliat Med"},{"key":"10.1016\/j.rpth.2026.103427_bib34","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.3399\/bjgp17X691073","article-title":"Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care","volume":"67","author":"Clyne","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.rpth.2026.103427_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","author":"Reeve","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rpth.2026.103427_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/ijpp\/riad005","article-title":"Healthcare professionals\u2019 perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework","volume":"31","author":"Alwidyan","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rpth.2026.103427_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276754","article-title":"Cancer patients\u2019 experiences of the diagnosis and treatment of incidental pulmonary embolism (a qualitative study)","volume":"17","author":"Benelhaj","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.103427_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/PPA.S79373","article-title":"Patients\u2019 Experiences of LIving with CANcer-associated thrombosis: the PELICAN study","volume":"9","author":"Noble","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.rpth.2026.103427_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.thromres.2020.06.024","article-title":"Patients experience of living with cancer associated thrombosis in France (Le PELICAN)","volume":"194","author":"Mah\u00e9","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103427_bib40","first-page":"3233","article-title":"Patients\u2019 Experience of Living with Cancer-associated thrombosis in Spain (PELICANOS)","volume":"26","author":"Font","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.rpth.2026.103427_bib41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/17512433.2023.2197592","article-title":"Perspectives on deprescribing in palliative care","volume":"16","author":"Tjia","year":"2023","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:17:57Z","timestamp":1790723877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2475037926000853"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103427","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinician perspectives on antithrombotic therapy management in advanced cancer: a multinational qualitative study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103427"}}